Information:
Fel:
Nyckelord
ПРОТИВООПУХОЛЕВЫЕ И ИММУНОДЕПРЕССИВНЫЕ СРЕДСТВА ×
- Clinical Trial (2)
- Clinical Trial, Phase II (2)
- Eligibility Determination (2)
- Lymphoma, B-Cell (1)
- Hospice Care (1)
- Carcinoma, Squamous Cell (1)
- Conjunctival Neoplasms (1)
- Head and Neck Neoplasms (1)
- Otorhinolaryngologic Diseases (1)
- Palliative Care (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
3 Sökresultat.
Item-grupper: Date, TT1. Type of therapy, TT2. Number of previous treatments, TT3. Indications, TT4. Agents/Regime/Modus, TT5. Medical indication assessed by, TT6. Palliative prognostic index PPI in pre-treatment/ starting the new indicated tumor treatment, TT7. Was proceding/start of tumor therapy based on consensus in the palliative team?, TT8. What was the subjective success of the tumor therapy?, TT9. Was the tumor therapy determined early?, TT10. If yes, what were the reasons for the discontinuation of tumor therapy?, TT11. Was discontinuation of tumor therapy based on consensus in the palliative team?, TT12. Who completes this questionnaire?
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Inclusion Criteria, Exclusion Criteria